Efe Eworuke

Oct 13, 2024 | onlinelibrary.wiley.com | Cheng Chen |Efe Eworuke |Ashish Rai |Laura Hou

Purpose On August 20, 2020, the United States (U.S.) Food and Drug Administration (FDA) issued a Drug Safety Communication (DSC) along with labeling updates to inform the public about a small increased risk of non-melanoma skin cancer (NMSC) associated with hydrochlorothiazide (HCTZ) use.